And Then There Were Five: Roche's Tecentriq Joins Europe I-O Race

 
• By Kevin Grogan
  
EU flag
Roche gets two approvals for Tecentriq - bladder and lung cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer